Home
About
Overview
Sharing Data
ORCID
Help
History (34)
Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience.
Inflammation and bacteriophages affect DNA inversion states and functionality of the gut microbiota.
A genome-wide screen for hyposmia susceptibility Loci.
Healthcare Failure Mode and Effect Analysis
Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development.
See All 34 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development.
Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development. Clin Gastroenterol Hepatol. 2019 08; 17(9):1673-1679.e1.
View in:
PubMed
subject areas
Clinical Trials as Topic
Colitis, Ulcerative
European Union
Government Agencies
Guidelines as Topic
Humans
Intestinal Mucosa
Patient Reported Outcome Measures
Treatment Outcome
United States
United States Food and Drug Administration
authors with profiles
David Rubin